Beamtree Holdings Ltd · ASX:BMT

Beamtree — Investor Presentation (February 2024)

32 slides from Beamtree's investor presentation, Feb 14, 2024

Slide 1: 1H FY24 Results
1H FY24 Results 14th February 2024
Slide 2: Important Notice and Disclaimer
Important Notice and Disclaimer The material in this presentation is general background information about Beamtree Holdings Limited (ASX:BMT) and is current at the date of the presentation, 14th February 2024. This presentation may contain statements that are, or may be deemed to be, forward looking
Slide 4: 1H FY24 Financial Highlights
1H FY24 Financial Highlights 20% PCP 23% 45% 38% PCP PCP PCP Annual Recurring Reported International Operating Profit Cash Revenue Revenue Revenue $24.2M $13.0M $4.7M $(0.5)M $5.1M* 1H FY23: $20.1M $10.5M $3.2M $(0.9)M $5.4M PCP: Prior Corresponding Period “PCP” 3
Slide 7: ARR organic year-on-year growth
+ ~20% organic YOY growth ~$60M 24.2 23.8 22.8 21.2 20.1 19.1 $24.2M 18.2 17.3 16.8 Q2 FY22 Q3 FY22 Q4 FY22 Q1 FY23 Q2 FY23 Q3 FY23 Q4 FY23 Q1 FY24 Q2 FY24 Q2 FY24 2026 Diagn. Coding CDS KN Copyright © Beamtree Holdings Limited – All Rights Reserved 6
Slide 9: ARR $60M target and main drivers of growth
Main Drivers of Growth: - Customer retention and upselling ~70% of the growth will come from ARR $60M overseas market. Abbott (3+2 year) contract with revenue share, pipeline growing ~35%~ 40% International direct RippleDown sales, pipeline growing ~15%~ 20% ARR $24.2M Sales of Clinical Decision Sup
Slide 12: Creating a better future for health
Creating a better future for health We provide AI decision support and data insights solutions with the aim of turning data into insights and action through automation. We believe it starts with better data and ends in better care – and that ‘better has no limit’
Slide 13: Beamtree is committed to supporting learning health systems
Beamtree is committed to supporting learning health systems
Slide 14: 25+ years of experience
ch 25+ years of experience Australian company with Australian IP h Q aa Diagnostic Technology Clinical Decision Support in leaders acute care RippleDown RippleDown’ Ainsoff Expert Auditor Deterioration Index oi Supporting healthcare globally / Fl Coding Assistance & Data Quality Picq risq Cutting-ed
Slide 15: The Problems We Help Solve
The Problems We Help Solve Ce Tackle unwarranted Offer revenue Promote transparency variation assurance Address equity Bridge knowledge gaps Increase efficiency, of access and resource reducing mistakes allocation Drive automation (\\ A Improve quality of data 4
Slide 19: International Growth: NHS pathfinder sites
International Growth : NHS pathfinder sites
Slide 20: International Growth: Saudi Arabia
International Growth: Saudi Arabia • • • • •
Slide 21: International Growth: British Columbia sites
International Growth: British Columbia sites
Slide 23: Annual Recurring Revenue Growth
Annual Recurring Revenue* (ARR) Growth ($’M) +20% organic PCP Comments +20% organic PCP • 24% growth in incremental ARR growth in 1HFY24 vs 1H FY23 4.1 • Main drivers (~80%) of ARR growth have 3.3 Diagnostics and our Coding products. • International growth, at 36% of reported 24.2 revenue and growin
Slide 24: 1H Reported Revenue Growth
1H Reported Revenue Growth ($’M) Comments +23% PCP (all organic) • Revenue growth contribution came from all four segments of Beamtree. +47% PCP 10% organic 2.5 • Increasing activity in Saudi Arabia and 0.7 Canada contributed to ~$1m of organic revenue growth. 2.7 • Coding growth of ~$0.5m was drive
Slide 25: 1H Operating Expenses & Investments
1H Operating Expenses & Investments ($’M) Comments • 1H FY24 operating expense grew 19% versus revenue growth of 23%. Non-employment +19% Annual organic growth rate • The main drivers of the $2.1m opex Employment +5.9% growth were: Annual organic growth rate 2.1 0.5 4.2 • $1.3m increase in employmen
Slide 26: Revenue & Operating Profit Trend and EBITDA
Revenue & Operating Profit Trend and EBITDA Reported revenue $m Adjustments to Operating Profit vs. reported EBITDA ($M) +10% Organic growth +23% Organic growth 1H FY22 1H FY23 1H FY24 Operating Profit (1.4) (0.9) (0.5) 12.3 12.9 9.4 10.5 7.1 Non operating expenses (cash) Transaction cost (0.1) 0.0
Slide 27: 1H Summary Profit and Loss
1H Summary Profit and Loss 1H FY24 1H FY23 Change P&L ($M) Actual Actual FY23-24 Group Revenue +23% Revenue 12.9 10.5 23% Annual recurring revenue (ARR) 24.2 20.1 20% Expenses – staff (9.3) (8.0) 16% Expenses – non staff (4.2) (3.4) 24% Opex +19% Total operating expenses (13.5) (11.4) 19% Operating
Slide 28: 1H Cashflow
1H Cashflow 1H FY24 1H FY23 Comments CF ($M) Actual Actual Operating cashflow Cash flows from operating activities • 1H FY24 operating cashflow impacted by delayed Receipts from customers (inclusive of GST) 14.0 13.4 receipt of ~$1.0m from international customer as Payments to suppliers and employee
Slide 29: 1H Balance Sheet
1H Balance Sheet Dec-23 Jun-23 Dec-22 BS ($M) Actual Actual Actual Cash Current assets Cash and cash equivalents Trade and other receivables 5.1 6.1 8.8 5.6 5.4 5.0 $5.1m Total current assets 11.2 14.4 10.4 2H burn expected to Non-current assets Property, plant and equipment 0.2 0.3 0.3 be materiall
Slide 30: Executive Summary 1H FY24 Highlights
Executive Summary 1H FY24 Highlights Annual recurring 1H Reported 1H International revenue revenue revenue $24.2M $13.0M $4.7M 20% 23% 45% PCP* PCP PCP 1H Operating 1H EBITDA 1H Net cash profit position $(0.5)M $(0.8)M +$5.1M +38% +63% PCP PCP Prior Corresponding Period “PCP” Copyright © Beamtree Ho

Beamtree Holdings — Investor Presentation (February 2024) on 6ix

Beamtree — Investor Presentation (February 2024)

Slide 1: 1H FY24 Results

Slide 2: Important Notice and Disclaimer

Slide 3: 1H FY24 Highlights

Slide 4: 1H FY24 Financial Highlights

Slide 5: Copyright © Beamtree Holdings Limited – All Rights Reserved

Slide 6: Copyright © Beamtree Holdings Limited – All Rights Reserved

Slide 7: ARR organic year-on-year growth

Slide 8: Operating profit trend by half

Slide 9: ARR $60M target and main drivers of growth

Slide 10: Copyright © Beamtree Holdings Limited – All Rights Reserved

Slide 11: Beamtree Strategy

Slide 12: Creating a better future for health

Slide 13: Beamtree is committed to supporting learning health systems

Slide 14: 25+ years of experience

Slide 15: The Problems We Help Solve

Slide 16: Copyright © Beamtree Holdings Limited – All Rights Reserved

Slide 17: Together with

Slide 18: International Expansion

Slide 19: International Growth: NHS pathfinder sites

Slide 20: International Growth: Saudi Arabia

Slide 21: International Growth: British Columbia sites

Slide 22: 1H FY24 Financial Results

Slide 23: Annual Recurring Revenue Growth

Slide 24: 1H Reported Revenue Growth

Slide 25: 1H Operating Expenses & Investments

Slide 26: Revenue & Operating Profit Trend and EBITDA

Slide 27: 1H Summary Profit and Loss

Slide 28: 1H Cashflow

Slide 29: 1H Balance Sheet

Slide 30: Executive Summary 1H FY24 Highlights

Slide 31: Copyright © Beamtree Holdings Limited – All Rights Reserved

Slide 32: Thank you